News related to Erbitux (Cetuximab) and/or conditions it is approved for
Cetuximab Continuation After CRC Progression May Up PFS
Source: Medscape Hematology-Oncology Headlines [2016.07.22]
Dr David Kerr reports on a phase 2 study suggesting that continuation of cetuximab after progression may improve progression-free survival in patients with metastatic colorectal cancer.
Genetic cause of 15 percent of colorectal cancer diagnoses identified
Source: Colorectal Cancer News From Medical News Today [2016.07.20]
Findings open up 'precision medicine' approach to prevention, diagnosis and treatment.
Internal radiation therapy: Better response in metastatic colorectal cancer patients
Source: Cancer / Oncology News From Medical News Today [2016.07.10]
New analysis shows patients with metastatic colorectal cancer treated with radiation therapy show better response than those receiving chemotherapy alone.
Colorectal cancer: Pivotal Phase III data for Xilonix presented
Source: Clinical Trials / Drug Trials News From Medical News Today [2016.07.05]
XBiotech Inc., developer of next-generation True Human™ antibody therapies, has presented positive results from a pivotal Phase III trial of Xilonix™, the company's lead monoclonal...
Anti-PD-L1 immunotherapy shows response in microsatellite-stable metastatic colorectal cancer in combination with MEK inhibition
Source: Colorectal Cancer News From Medical News Today [2016.07.04]
Anti-PD-L1 immunotherapy may achieve a response in patients with microsatellite-stable metastatic colorectal cancer if combined with a MEK inhibitor, according to phase I data presented at the ESMO...
Are older adults being appropriately screened for colorectal cancer?
Source: Colorectal Cancer News From Medical News Today [2016.06.23]
Who should consider colorectal cancer (CRC) screening and why? CRC is a common and costly disease, largely of the elderly, with nearly 25% of cases diagnosed among patients aged 75-84 years, but...
U.S. preventive services task force updates recommendations regarding screening for colorectal cancer
Source: Colorectal Cancer News From Medical News Today [2016.06.16]
The U.S. Preventive Services Task Force (USPSTF) found convincing evidence that colorectal cancer screening substantially reduces deaths from the disease among adults 50 to 75 years of age and that...
Colorectal Cancer (Colon Cancer): Symptoms, Signs, Screening, Stages, and Treatment Options
Source: MedicineNet Anemia Specialty [2016.06.07]
Title: Colorectal Cancer (Colon Cancer): Symptoms, Signs, Screening, Stages, and Treatment Options
Created: 9/21/2009 12:59:00 PM
Last Editorial Review: 6/7/2016 12:00:00 AM
Colorectal cancer rate rising among younger people
Source: Colorectal Cancer News From Medical News Today [2016.05.25]
Researchers find cancers are more advanced in those diagnosed before 50.A new study shows the rate of colorectal cancer (CRC) continues to increase in individuals under 50 years old, despite the...
Cholesterol levels, not statins, influence colorectal cancer risk
Source: Statins News From Medical News Today [2016.04.27]
Indication bias' may explain link between statin use and cancer risk. Long-term use of the cholesterol-lowering drugs known as statins does not appear to decrease a patient's risk of...
Confounding rather than causation may explain association between statin use and lower risk of colorectal cancer
Source: Statins News From Medical News Today [2016.04.26]
Both statin use and increased cholesterol have been linked to lower risk of colorectal cancer.
Link between obesity and increased risk of colorectal cancer revealed
Source: Irritable Bowel Syndrome News From Medical News Today [2016.01.18]
Obesity has long been associated with increased risk of colorectal cancer, but the link has never been understood.
Colorectal Cancer Pictures Slideshow: Understanding Cancer of the Colon
Source: MedicineNet Rectal Bleeding Specialty [2013.06.07]
Title: Colorectal Cancer Pictures Slideshow: Understanding Cancer of the Colon
Created: 9/21/2009 12:59:00 PM
Last Editorial Review: 6/7/2013 12:00:00 AM
Antidepressants might reduce risk of colorectal cancer
Source: The Doctors Lounge - Psychiatry
Use of serotonin reuptake inhibitors (SSRI) might inhibit the growth of colorectal tumors according to The Lancet Oncology.
Oxaliplatin-Based Adjuvant Chemo for Stage III MMR CRC
Source: Medscape General Surgery Headlines [2016.07.22]
Oxaliplatin-based adjuvant chemotherapy was be better than surgery alone for patients with stage 3 colorectal cancer with mutations in DNA mismatch repair genes.
Medscape Medical News
Personalized Care of Metastatic CRC Highlighted by ESMO
Source: Medscape General Surgery Headlines [2016.07.21]
Physicians treating metastatic colorectal cancer should combine the patient's condition with appropriate treatment goals and molecular tumor profiling to personalize care, say European experts.
Medscape Medical News
Regulatory T cells' involvement in the progress of colon cancer
Source: Colorectal Cancer News From Medical News Today [2016.07.06]
Researchers at Osaka University, clarified that T-lymphocytes expressing FOXP3 at a low level found in colorectal cancers (CRCs) facilitated cancer immunity.
Dietary experiments in mice point the way to early detection of cancer development in humans
Source: Colorectal Cancer News From Medical News Today [2016.05.23]
Colorectal cancer is the second most common cause of cancer-related deaths in the Western world, mainly because it is usually diagnosed too late.
Blocking known cancer driver unexpectedly reveals a new tumor-promoting pathway
Source: Colorectal Cancer News From Medical News Today [2016.05.18]
Targeting both pathways with drug inhibitors more effective in stopping colorectal cancer growth.
Cancer patients with depression less likely to recover well after treatment
Source: Colorectal Cancer News From Medical News Today [2016.05.16]
A new study finds colorectal cancer patients with depression are seven times more likely to be in very poor health 2 years after end of treatment than patients without depression.